← Back to Discover
Samsara BioCapital, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $1,217,462,122
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- SCHOLAR ROCK HLDG CORP · COM · 80706P103 · shares: $379,370,860
- ALUMIS INC · COM · 022307102 · shares: $178,554,463
- MINERALYS THERAPEUTICS INC · COM · 603170101 · shares: $158,400,066
- SEPTERNA INC · COM · 81734D104 · shares: $105,464,297
- ALAMAR BIOSCIENCES INC · COMMON STOCK · 010911105 · shares: $67,191,598
- NEUROGENE INC · COM · 64135M105 · shares: $54,003,644
- KALARIS THERAPEUTICS INC · COM · 482929106 · shares: $52,426,382
- SPYGLASS PHARMA INC · COM SHS · 85220G109 · shares: $46,967,554
- SUTRO BIOPHARMA INC · COM SHS · 869367201 · shares: $35,287,350
- INVENTIVA SA · ADS · 46124U107 · shares: $23,869,963
Reported holdings
24 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 6,897,652 shares | $379,370,860 |
| ALUMIS INC | COM | 022307102 | — | 6,345,219 shares | $178,554,463 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 5,871,018 shares | $158,400,066 |
| SEPTERNA INC | COM | 81734D104 | — | 3,149,128 shares | $105,464,297 |
| ALAMAR BIOSCIENCES INC | COMMON STOCK | 010911105 | — | 2,480,310 shares | $67,191,598 |
| NEUROGENE INC | COM | 64135M105 | — | 1,717,127 shares | $54,003,644 |
| KALARIS THERAPEUTICS INC | COM | 482929106 | — | 12,881,175 shares | $52,426,382 |
| SPYGLASS PHARMA INC | COM SHS | 85220G109 | — | 2,109,953 shares | $46,967,554 |
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | — | 1,062,872 shares | $35,287,350 |
| INVENTIVA SA | ADS | 46124U107 | — | 6,314,805 shares | $23,869,963 |
| JADE BIOSCIENCES INC | COM NEW | 008064206 | — | 736,237 shares | $16,359,186 |
| PARABILIS MEDICINES INC | COM | 698955101 | — | 556,044 shares | $15,218,924 |
| VTV THERAPEUTICS INC | CL A NEW | 918385204 | — | 298,496 shares | $11,238,374 |
| AQUESTIVE THERAPEUTICS INC | COM | 03843E104 | — | 2,500,000 shares | $10,400,000 |
| NKARTA INC | COM | 65487U108 | — | 3,507,666 shares | $9,926,695 |
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | — | 954,861 shares | $9,262,152 |
| RANI THERAPEUTICS HLDGS INC | COM CL A | 753018100 | — | 10,369,159 shares | $7,884,709 |
| AGOMAB THERAPEUTICS NV | SPONSORED ADS | 00860C102 | — | 600,000 shares | $7,788,000 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 55,095 shares | $7,341,960 |
| X4 PHARMACEUTICALS INC | COM NEW | 98420X202 | — | 1,395,587 shares | $6,517,391 |
| ELOXX PHARMACEUTICALS INC | COM NEW | 29014R301 | — | 400,000 shares | $5,552,000 |
| COHERUS ONCOLOGY INC | COM | 19249H103 | — | 3,428,571 shares | $4,799,999 |
| UPSTREAM BIO INC | COM | 91678A107 | — | 353,717 shares | $2,447,722 |
| GOSSAMER BIO INC | COM | 38341P102 | — | 7,222,559 shares | $1,188,833 |